263 related articles for article (PubMed ID: 7459859)
21. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
[TBL] [Abstract][Full Text] [Related]
22. Radioimmunoassay of prostatic acid phosphatase in carcinoma of the prostate.
N Engl J Med; 1978 Apr; 298(16):912-3. PubMed ID: 634336
[No Abstract] [Full Text] [Related]
23. [Significance of an immunoenzyme assay of the prostate-specific acid phosphatase (PAP) (E.C.3.1.3.2.) in prostatic carcinoma. Methods and initial clinical results].
Bauer HW; Schmiedt E
Urologe A; 1983 Sep; 22 Suppl():367-71. PubMed ID: 6195796
[TBL] [Abstract][Full Text] [Related]
24. Immunoreactive prostatic acid phosphatase in prostatic cancer: diagnosis and followup of patients.
Vihko P; Kontturi M; Lukkarinen O; Vihko R
J Urol; 1985 Jun; 133(6):979-82. PubMed ID: 3999224
[TBL] [Abstract][Full Text] [Related]
25. [Radioimmunoassay for prostatic acid phosphatase in human serum. Methodologic aspects (author's transl)].
Pradalier N; Canal P; Pujol A; Fregevu Y; Soula G
Ann Biol Clin (Paris); 1982; 40(1):45-50. PubMed ID: 7200750
[TBL] [Abstract][Full Text] [Related]
26. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
Sharief FS; Mohler JL; Sharief Y; Li SS
Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
[TBL] [Abstract][Full Text] [Related]
27. [Acid phosphatases].
Chiche R; Steg A
Sem Hop; 1983 Jun; 59(22):1709-16. PubMed ID: 6308797
[TBL] [Abstract][Full Text] [Related]
28. [Laboratory tools in the diagnosis of prostatic cancer (author's transl)].
Jacobi GH
Urologe A; 1979 Nov; 18(6):311-5. PubMed ID: 388799
[TBL] [Abstract][Full Text] [Related]
29. [Diurnal variation of the elevated acid phosphatase activity in cases of prostate carcinoma (author's transl)].
Wisser H; Knoll E; Schmid G
J Clin Chem Clin Biochem; 1980 May; 18(5):297-301. PubMed ID: 7191887
[TBL] [Abstract][Full Text] [Related]
30. Elevated levels of serum secretoneurin in patients with therapy resistant carcinoma of the prostate.
Ischia R; Hobisch A; Bauer R; Weiss U; Gasser RW; Horninger W; Bartsch G; Fuchs D; Bartsch G; Winkler H; Klocker H; Fischer-Colbrie R; Culig Z
J Urol; 2000 Apr; 163(4):1161-4; discussion 1164-5. PubMed ID: 10737487
[TBL] [Abstract][Full Text] [Related]
31. Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
Vihko P; Kontturi M; Lukkarinen O; Vihko R
J Urol; 1982 Oct; 128(4):739-41. PubMed ID: 6183458
[TBL] [Abstract][Full Text] [Related]
32. A simple immunohistochemical method for the detection of prostatic acid phosphatase.
Lee P; Lam KW; Li CY; Yam LT
Arch Pathol Lab Med; 1981 Apr; 105(4):205-6. PubMed ID: 7011253
[TBL] [Abstract][Full Text] [Related]
33. Immunologic markers and the diagnosis of prostatic cancer.
Ban Y; Wang MC; Chu TM
Urol Clin North Am; 1984 May; 11(2):269-76. PubMed ID: 6203206
[TBL] [Abstract][Full Text] [Related]
34. Modern concepts of acid and alkaline phosphatase measurement.
Beckley S; Chu TM; Wajsman Z; Mittelman A; Slack N; Murphy GP
Scand J Urol Nephrol Suppl; 1980; 55():65-70. PubMed ID: 6938038
[TBL] [Abstract][Full Text] [Related]
35. Prostatic acid phosphatase: current concepts.
Romas NA
Semin Urol; 1983 Aug; 1(3):177-85. PubMed ID: 6379804
[TBL] [Abstract][Full Text] [Related]
36. Monitoring and treatment of minimal residual cancer of the prostate.
Mathé G; Schally AV; Comaru-Schally AM; Mauvernay RY; Vovan ML; Machover D; Misset JL; Court B; Bouchard P; Duchier J
Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):65-74. PubMed ID: 2525968
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow acid phosphatase in prostate cancer: an assessment by immunoassay and biochemical methods.
Romas NA; Veenema RJ; Hsu KC; Tomashefsky P; Lattimer JK; Tannenbaum M
Trans Am Assoc Genitourin Surg; 1979; 71():26-30. PubMed ID: 545810
[TBL] [Abstract][Full Text] [Related]
38. [Reliability and use of prostate-specific antigen in the management of patients with prostatic cancer].
Hübler J; Jávor A
Orv Hetil; 1993 Jul; 134(28):1529-32. PubMed ID: 7688112
[TBL] [Abstract][Full Text] [Related]
39. The radioimmunochemical measurement of prostatic acid phosphatase: current state of the art.
Cooper JF
Urol Clin North Am; 1980 Oct; 7(3):653-65. PubMed ID: 6161460
[TBL] [Abstract][Full Text] [Related]
40. [Acid phosphatase in blood (substrate: alpha-naphthylphosphate): reference values and diagnostic significance].
Seiler D; Nagel D; Tritschler W; Looser S
J Clin Chem Clin Biochem; 1983 Aug; 21(8):519-25. PubMed ID: 6355367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
